UK markets closed
NIKKEI 225
27,362.75 -32.26 (-0.12%) HANG SENG
22,566.78 +522.13 (+2.37%) CRUDE OIL
81.15 +0.14 (+0.17%) GOLD FUTURES
1,930.00 0.00 (0.00%) DOW
33,949.41 +205.57 (+0.61%) BTC-GBP
18,533.92 -87.67 (-0.47%)
Corcept Therapeutics Incorporated (0I3Q.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:10PM GMT
| Previous close | 22.73 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 23.128M |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 0.25 |
| EPS (TTM) | 0.91 |
| Earnings date | 13 Feb 2023 - 17 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Estimating The Intrinsic Value Of Corcept Therapeutics Incorporated (NASDAQ:CORT)
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
- Zacks
Corcept (CORT) Rides on Robust Korlym Sales, High Reliance a Woe
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
- Zacks
Durect (DRRX) Soars 11.8%: Is Further Upside Left in the Stock?
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
© 2023 Yahoo. All rights reserved.
